--- title: "NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023" ocid: "ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0.json" source: "Contracts Finder" current_stage: "Award" buyer: "NHS ENGLAND" published: "2023-03-24" --- # NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Buyer: NHS ENGLAND Current stage: Award OCID: ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0.json) ## Summary The NHS England has recently awarded a National Framework Agreement for the supply of Adalimumab Injection with a total value of £264,003,000. The procurement stage was an open procedure above the threshold, with a tender period ending on 28th November 2022. The contract period covers 1st April 2023 to 28th February 2026. The industry category is Pharmaceutical products, and the contract was awarded on 3rd March 2023. This tender presents significant business opportunities for suppliers in the pharmaceutical industry who specialize in the supply of Adalimumab Injection. Small and medium-sized enterprises (SMEs) can benefit from this framework agreement, as it involves multiple regions across the UK. Businesses with experience in large-scale pharmaceutical supply contracts are well-suited to compete in this procurement process, paving the way for sustainable business growth and expansion. ## Notice Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660 | | Notice type | Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure (above threshold) | | Tender suitability | SME | | Awardee scale | Large, SME | | All stages | Award | ## Dates | Field | Value | | --- | --- | | Publication date | 24 Mar 2023 | | Submission deadline | 28 Nov 2022 | | Future notice date | Not specified | | Award date | 3 Mar 2023 | | Contract period | 31 Mar 2023 - 28 Feb 2026 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £264,003,000 | | Lots value | Not specified | | Awards value | £264,003,228 | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Not specified | | Awards status | Active | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | RUNCORN | | Post town | Warrington | | Postcode | WA7 2ES | | Country | England | | ITL 1 | TLD North West (England) | | ITL 2 | TLD7 Merseyside | | ITL 3 | TLD71 East Merseyside | | Local authority | Halton | | Electoral ward | Halton Lea | | Westminster constituency | Runcorn and Helsby | | Delivery location | TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England) | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 6 | | Supplier names | ABBVIE; AMGEN; BIOGEN; CELLTRION HEALTHCARE UNITED KINGDOM; FRESENIUS KABI; SANDOZ | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 24 Mar 2023 at 11:46 - Award - Award Notice - https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660 ## Documents - https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660 24th March 2023 - Awarded contract notice on Contracts Finder - https://www.contractsfinder.service.gov.uk/Notice/Attachment/28fe1d39-9c1b-4293-9b1f-9ec053766193 5660_02 Transparency Award Schedule - https://www.contractsfinder.service.gov.uk/Notice/Attachment/16647a0d-d52c-4e25-89a2-88ccd1f97e7e 5660_03 Transparency Award Schedule - https://www.contractsfinder.service.gov.uk/Notice/Attachment/2dc44a21-0812-4592-944e-7dd9285f07b0 5660_04 Transparency Award Schedule - https://www.contractsfinder.service.gov.uk/Notice/Attachment/c9c6a1c5-0c14-4c52-9d09-b40887c92179 030223-2022 FTS Opportunity National Framework Agreement for Adalimumab Injection 1 April 2023 - https://www.contractsfinder.service.gov.uk/Notice/Attachment/2d836161-4648-499c-9ea5-2ca8cb1ef685 5660_01 Transparency Award Schedule - https://www.contractsfinder.service.gov.uk/Notice/Attachment/29ee5fb1-a16a-4c69-9084-4b70c029fc65 Parties Appointed to the framework CM-PHR-22-5660 - https://www.contractsfinder.service.gov.uk/Notice/Attachment/7e2ab6fb-bde7-4919-a5b6-7c5b4ef397f7 03 Framework Agreement and Terms and Conditions - CM_PHR_22_5660 - National Framework Agreement for Adalimumab Injection April 2023 ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0.json.